GSK3145095
Product Specifications
CAS Number
1622849-43-7
Target
RIP kinase
Related Pathways
Apoptosis|||NF-?B
Purity
>99.99%
Bioactivity
GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic.
Smiles
Fc1cc(F)c2NC(=O)[C@H](CCc2c1)NC(=O)c1n[nH]c(Cc2ccccc2)n1
Molecular Formula
C20H17F2N5O2
Molecular Weight
397.38
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1079430-01 0.02 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details 
MBS1079430-02 0.02 mg (Yeast)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1079430-03 0.1 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details 
MBS1079430-04 0.1 mg (Yeast)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1079430-05 0.02 mg (Baculovirus)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1079430-06 0.02 mg (Mammalian-Cell)
Recombinant Streptococcus agalactiae serotype V UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details